Physician profile
John D Polansky
NPI 1942208640
$2,107.32
in general payments reported to CMS, 2019-2025
18 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $275 · 2021: $150 · 2022: $179 · 2023: $325 · 2024: $388 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,081.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $392.71 | 2019-2025 | |
| Alcon Vision LLC | $388.42 | 2019-2022 | |
| Allergan, INC. | $198.70 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $197.25 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $178.76 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Horizon Therapeutics Plc | $153.80 | 2022-2023 | Tepezza |
| Heidelberg Engineering, INC. | $93.69 | 2025 | Spectralis |
| Aerie Pharmaceuticals, INC. | $89.82 | 2019-2020 | |
| Oyster Point Pharma, INC. | $81.99 | 2023-2024 | Tyrvaya |
| Rxsight INC | $69.20 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Sight Sciences, INC. | $55.16 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Biotissue Holdings INC. | $48.10 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $43.62 | 2019 | |
| Thea Pharma INC. | $33.89 | 2023-2025 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $33.80 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $17.93 | 2024 | Izervay |
| Johnson & Johnson Surgical Vision, INC. | $17.80 | 2019 | |
| Ivantis, INC | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Polansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.